The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

BACKGROUND: To evaluate the cost-effectiveness of growth hormone (GH) treatment (Genotropin®) compared with no GH treatment in adults with GH deficiency in a Swedish societal setting. METHODS: A Markov-type cost-utility simulation model was constructed and used to simulate, for men and women, morbid...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolin, Kristian, Sandin, Rickard, Koltowska-Häggström, Maria, Loftus, Jane, Prütz, Christin, Jonsson, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850881/
https://www.ncbi.nlm.nih.gov/pubmed/24079522
http://dx.doi.org/10.1186/1478-7547-11-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850881/
https://www.ncbi.nlm.nih.gov/pubmed/24079522
http://dx.doi.org/10.1186/1478-7547-11-24

Ejemplares similares